ELX/TEZ/IVA Expanded Access Program for Cystic Fibrosis (CF) Patients With at Least One F508del Mutation
Clinical trial NCT04702360 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04702360
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.